|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
12,090,000 |
Market
Cap: |
2.37(M) |
Last
Volume: |
4,012,246 |
Avg
Vol: |
3,979,937 |
52
Week Range: |
$0.1961 - $0.1961 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Aethlon Medical is a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases. The Aethlon Hemopurifier® (Hemopurifier) is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. Co. is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rossetti Angela |
Director |
|
2025-04-23 |
4 |
A |
$0.35 |
$50,000 |
D/D |
142,857 |
343,400 |
|
- |
|
Broenniman Edward G |
Director |
|
2025-04-23 |
4 |
A |
$0.35 |
$50,000 |
D/D |
142,857 |
181,741 |
|
- |
|
Gikakis Nicolas |
Director |
|
2025-04-23 |
4 |
A |
$0.35 |
$50,000 |
D/D |
142,857 |
174,320 |
|
- |
|
Shah Chetan |
Director |
|
2025-04-23 |
4 |
A |
$0.36 |
$51,143 |
D/D |
142,857 |
174,233 |
|
- |
|
Gikakis Nicolas |
Director |
|
2025-03-31 |
4 |
D |
$0.36 |
$1,177 |
D/D |
(3,289) |
31,463 |
|
- |
|
Shah Chetan |
Director |
|
2025-03-31 |
4 |
D |
$0.36 |
$1,177 |
D/D |
(3,289) |
31,376 |
|
- |
|
Broenniman Edward G |
Director |
|
2025-03-31 |
4 |
D |
$0.36 |
$589 |
D/D |
(1,645) |
38,884 |
|
- |
|
Broenniman Edward G |
Director |
|
2024-12-31 |
4 |
D |
$0.86 |
$1,415 |
D/D |
(1,645) |
40,529 |
|
- |
|
Shah Chetan |
Director |
|
2024-12-31 |
4 |
D |
$0.86 |
$2,829 |
D/D |
(3,289) |
34,665 |
|
- |
|
Gikakis Nicolas |
Director |
|
2024-12-31 |
4 |
D |
$0.86 |
$2,829 |
D/D |
(3,289) |
34,752 |
|
- |
|
Broenniman Edward G |
Director |
|
2024-09-30 |
4 |
D |
$0.47 |
$767 |
D/D |
(1,645) |
42,174 |
|
- |
|
Gikakis Nicolas |
Director |
|
2024-09-30 |
4 |
D |
$0.47 |
$1,533 |
D/D |
(3,289) |
38,041 |
|
- |
|
Shah Chetan |
Director |
|
2024-09-30 |
4 |
D |
$0.47 |
$1,533 |
D/D |
(3,289) |
37,954 |
|
- |
|
Gikakis Nicolas |
|
|
2024-06-28 |
4 |
D |
$0.50 |
$2,617 |
D/D |
(5,244) |
41,330 |
|
- |
|
Shah Chetan |
|
|
2024-06-28 |
4 |
D |
$0.50 |
$1,641 |
D/D |
(3,289) |
41,243 |
|
- |
|
Broenniman Edward G |
|
|
2024-06-28 |
4 |
D |
$0.50 |
$821 |
D/D |
(1,645) |
43,819 |
|
- |
|
Shah Chetan |
|
|
2024-04-16 |
4 |
A |
$1.52 |
$49,999 |
D/D |
32,894 |
44,532 |
|
- |
|
Broenniman Edward G |
|
|
2024-04-16 |
4 |
A |
$1.52 |
$49,999 |
D/D |
32,894 |
45,464 |
|
- |
|
Gikakis Nicolas |
|
|
2024-04-16 |
4 |
A |
$1.52 |
$49,999 |
D/D |
32,894 |
46,574 |
|
- |
|
Rossetti Angela |
|
|
2024-04-16 |
4 |
A |
$1.52 |
$49,999 |
D/D |
32,894 |
200,543 |
|
- |
|
Broenniman Edward G |
|
|
2024-03-29 |
4 |
D |
$1.68 |
$1,954 |
D/D |
(1,163) |
12,570 |
|
- |
|
Shah Chetan |
|
|
2024-03-29 |
4 |
D |
$1.68 |
$1,954 |
D/D |
(1,163) |
11,638 |
|
- |
|
Gikakis Nicolas |
|
|
2024-03-29 |
4 |
D |
$1.68 |
$3,283 |
D/D |
(1,954) |
13,680 |
|
- |
|
Broenniman Edward G |
Director |
|
2023-12-29 |
4 |
D |
$2.19 |
$2,547 |
D/D |
(1,163) |
13,733 |
|
- |
|
Shah Chetan |
Director |
|
2023-12-29 |
4 |
D |
$2.19 |
$2,547 |
D/D |
(1,163) |
12,801 |
|
- |
|
151 Records found
|
|
Page 1 of 7 |
|
|